???pagination.result.count???
???pagination.result.page??? 1 2 ???pagination.result.next???
| Organization | Type | Description |
|---|---|---|
| C.M.B. Association | Publisher | |
| C4RCD Research Group | University | |
| Cairo, Egypt : Hindawi Pub. Corp | Publisher | |
California Institute for Regenerative Medicine (CIRM) 
|
Government Orgnization | CIRM, California’s Stem Cell Agency, was created by the voters of California in 2004 when they overwhelmingly passed Proposition 71, which authorized $3 billion in funding for stem cell research in California. The agency funds stem cell research at institutions and companies throughout California (as well as institutions and companies outside of the state that conduct a portion of their research in California) with the goal of accelerating treatments to patients with unmet medical needs. Here is the text of Proposition 71. In 2020, California voters approved to continue funding California’s Stem Cell Agency through the passage of Proposition 14: The California Stem Cell Research, Treatments, and Cures Initiative of 2020. |
| Cambridge (Eng) : Elsevier Trends Journals | Publisher | |
| Cambridge : Cambridge University Press, c2004- | Publisher | |
| Cambridge : Company of Biologists | Publisher | |
| Cambridge : Company of Biologists Ltd | Publisher | |
| Cambridge : Company of Biologists Ltd., c2008- | Publisher | |
| Cambridge : Elsevier Trends Journals | Publisher | |
| Cambridge : Royal Society of Chemistry | Publisher | |
| Cambridge : RSC Pub., 2009- | Publisher | |
| Cambridge : RSC Publishing, c2009- | Publisher | |
| Cambridge ; New York, NY : Cambridge University Press, c1993- | Publisher | |
| Cambridge [England] : Royal Society of Chemistry, c1999- | Publisher | |
| Cambridge Eng : Company Of Biologists | Publisher | |
| Cambridge Eng : Company Of Biologists Limited | Publisher | |
| Cambridge Ma : Cell Press | Publisher | |
| Cambridge Univ. Press | Publisher | |
| Cambridge Univ. Press for the Company of Biologists Ltd. [etc.] | Publisher | |
| Cambridge Univ. Press. | Publisher | |
| Cambridge University Press | Publisher | |
| Cambridge University Press. | Publisher | |
| Cambridge, Eng : Wiley-Blackwell | Publisher | |
| Cambridge, England : Cambridge University Press | Publisher | |
| Cambridge, MA : Cell Press | Publisher | |
| Cambridge, Ma : Cell Press | Publisher | |
| Cambridge, MA : Cell Press, 2016- | Publisher | |
| Cambridge, Mass. : Cell Press | Publisher | |
| Cambridge, Mass. : Cell Press, c2001- | Publisher | |
| Cambridge, Mass. : Cell Press, c2002- | Publisher | |
| Cambridge, Mass. : Cell Press, c2005- | Publisher | |
| Cambridge, UK : eLife Sciences Publications, Ltd., 2012- | Publisher | |
| Cambridge, UK : Elsevier Science Publishers, c1991- | Publisher | |
| Cambridge, UK : Royal Society of Chemistry, 2005- | Publisher | |
| Cambridge, UK : Royal Society of Chemistry, [2010]- | Publisher | |
| Cambridge, UK : Royal Society of Chemistry, c2001- | Publisher | |
| Cambridge, UK : Royal Society of Chemistry, c2003- | Publisher | |
| Canadian Medical Association | Publisher | |
|
Canadian Society for Pharmaceutical Sciences
|
Publisher | The Canadian Society for Pharmaceutical Sciences publishes the Journal of Pharmacy & Pharmaceutical Sciences. http://ejournals.library.ualberta.ca/index.php/JPPS/issue/current. |
| Canadian Veterinary Medical Association | Publisher | |
| Cancer Genome Project | Paper Author | |
| Candler, NC : Allied Academies | Publisher | |
| Carlton, Vic. : Wiley on behalf of the Japanese Teratology Society | Publisher | |
| Cary, NC : Oxford University Press | Publisher | |
|
CAUSES Study
|
Non-Governmental Organization | Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology |
|
CD BioGlyco
|
Company | CD BioGlyco is the world's leading independent biotechnology company, attracting a large number of researchers and partners, and has provided high-quality products and services for thousands of researchers worldwide. CD BioGlyco is committed to discovering, developing, manufacturing and providing innovative glycobiology-related high-quality products and services, as well as solutions that can improve research results and increase the speed of success. We aim to provide customers with high-satisfaction assistance in glycobiology research, and save time, effort and money for customers while obtaining perfect data. |
|
CD Bioparticles
|
Company | CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. |
|
CD Genomics
|
Company | Description: CD Genomics is aiming at providing the research community with high-quality Next Generation Sequencing and high-throughput microarray services. Due to the demand for our services having increased, CD Genomics has already updated its technology platform to mainstream NGS and microarray instruments. At present, our senior bioinformaticians have viewed more than ten thousand trace files and accumulated abundant experience with our Illumina HiSeq2000/2500, Illumia Miseq, Ion Torrent PGM, PacBio RS, and ABI 3730/3730XL analyzers. We will continue to work hard to offer you the same dependable services to pharmaceutical and biotech companies, as well as academia and government agencies, for the purpose of satisfying all your sequencing or array needs. |
| Cell Press | Publisher |
???pagination.result.page??? 1 2 ???pagination.result.next???